Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: https://medlineplus.gov/genetics/condition/bardet-biedl-syndrome/

Bardet-Biedl syndrome

Description

Bardet-Biedl syndrome is a disorder that affects many parts of the body. The specific features and the course of this condition can vary greatly among affected individuals.

Vision loss is one of the major features of Bardet-Biedl syndrome. Most affected individuals have a condition called cone-rod dystrophy in which the light-sensing tissue at the back of the eye (the retina) breaks down over time. Cone-rod dystrophy typically begins with problems with night vision during childhood, followed by blind spots that develop in the side (peripheral) vision. Over time, these blind spots enlarge and merge to produce tunnel vision. Most people with Bardet-Biedl syndrome also develop blurred central vision (poor visual acuity) and become legally blind by adolescence or early adulthood.

Obesity is another characteristic feature of Bardet-Biedl syndrome. Abnormal weight gain typically begins during the first months or years after birth and continues to be an issue throughout life. Complications of obesity can include type 2 diabetes, high blood pressure (hypertension), and abnormally high cholesterol levels (hypercholesterolemia).

Other common signs and symptoms of Bardet-Biedl syndrome include the presence of extra fingers or toes (polydactyly), learning problems, and intellectual disabilities. Some people have genital abnormalities, which can include an underdeveloped or abnormally developed penis, uterus, or vagina. Affected individuals may have reduced levels of sex hormones (hypogonadism) and difficulties having biological children. Many people with Bardet-Biedl syndrome also have kidney abnormalities, which can be serious or life-threatening.

Additional features of Bardet-Biedl syndrome can include impaired speech; delayed development of motor skills, such as standing and walking; and behavioral issues, such as anxiety and mood disorders. Distinctive facial features, dental abnormalities, unusually short or fused fingers or toes, and a partial or complete loss of the sense of smell (anosmia) can also occur in people with Bardet-Biedl syndrome. Additionally, this condition can affect the heart, liver, and digestive system.

Frequency

In most of North America and Europe, Bardet-Biedl syndrome affects 1 in 120,000 to 160,000 newborns. The condition is more common on the island of Newfoundland (off the east coast of Canada) and in certain populations of Kuwait. Bardet-Bieldl syndrome is most common on the Faroe Islands in the North Atlantic Ocean, where it affects 1 in 3,700 newborns.

Causes

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in at least 26 different genes (often called the BBS genes) cause Bardet-Biedl syndrome. These genes are known or suspected to play important roles in the function of certain types of cilia. Cilia are microscopic projections that stick out from the surface of most cells. Primary cilia are a specific type of cilia that transmit signals from the outside of the cell to the inside. They are necessary for the perception of sensory input (such as sight, hearing, and smell), and they play an important role in cell communication. The proteins produced from the BBS genes are involved in the maintenance and function of primary cilia.

Variants in BBS genes lead to problems with the structure or function of primary cilia. Changes in these cell structures likely disrupt important signaling pathways during development, including those that affect cell growth and division (proliferation) and cell specialization (differentiation). Researchers believe that most of the features of Bardet-Biedl syndrome are caused by cilia that do not function properly.

About 23 percent of all cases of Bardet-Biedl syndrome result from variants in the BBS1 gene. Another 15 percent of cases are caused by variants in the BBS10 gene. Variants in the other BBS genes account for only a small percentage of all cases of this condition. In about 20 to 30 percent of people with Bardet-Biedl syndrome, the cause of the disorder is unknown.

The presence of variants in more than one gene may explain the variability in the features and the course of Bardet-Biedl syndrome. These additional genes may be BBS genes or other genes, and variants in these genes may help modify the course of the condition. However, this phenomenon appears to be uncommon, and it has not been found consistently in scientific studies.

Learn more about the genes associated with Bardet-Biedl syndrome

Additional Information from NCBI Gene:

Inheritance

Bardet-Biedl syndrome is typically inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a pathogenic variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

  • BBS

Additional Information & Resources

Genetic Testing Information

Genetic and Rare Diseases Information Center

Patient Support and Advocacy Resources

Clinical Trials

Catalog of Genes and Diseases from OMIM

Scientific Articles on PubMed

References

  • Baker K, Beales PL. Making sense of cilia in disease: the human ciliopathies. Am J Med Genet C Semin Med Genet. 2009 Nov 15;151C(4):281-95. doi: 10.1002/ajmg.c.30231. Citation on PubMed
  • Beales PL. Lifting the lid on Pandora's box: the Bardet-Biedl syndrome. Curr Opin Genet Dev. 2005 Jun;15(3):315-23. doi: 10.1016/j.gde.2005.04.006. Citation on PubMed
  • Dollfus H, Lilien MR, Maffei P, Verloes A, Muller J, Bacci GM, Cetiner M, van den Akker ELT, Grudzinska Pechhacker M, Testa F, Lacombe D, Stokman MF, Simonelli F, Gouronc A, Gavard A, van Haelst MM, Koenig J, Rossignol S, Bergmann C, Zacchia M, Leroy BP, Mosbah H, Van Eerde AM, Mekahli D, Servais A, Poitou C, Valverde D. Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations. Eur J Hum Genet. 2024 Nov;32(11):1347-1360. doi: 10.1038/s41431-024-01634-7. Epub 2024 Jul 31. Citation on PubMed
  • Forsyth R, Gunay-Aygun M. Bardet-Biedl Syndrome Overview. 2003 Jul 14 [updated 2023 Mar 23]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1363/ Citation on PubMed
  • Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet. 2013 Jan;21(1):8-13. doi: 10.1038/ejhg.2012.115. Epub 2012 Jun 20. Citation on PubMed
  • Katsanis N, Ansley SJ, Badano JL, Eichers ER, Lewis RA, Hoskins BE, Scambler PJ, Davidson WS, Beales PL, Lupski JR. Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science. 2001 Sep 21;293(5538):2256-9. doi: 10.1126/science.1063525. Citation on PubMed
  • Katsanis N. The oligogenic properties of Bardet-Biedl syndrome. Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R65-71. doi: 10.1093/hmg/ddh092. Epub 2004 Feb 19. Citation on PubMed
  • Manara E, Paolacci S, D'Esposito F, Abeshi A, Ziccardi L, Falsini B, Colombo L, Iarossi G, Pilotta A, Boccone L, Guerri G, Monica M, Marta B, Maltese PE, Buzzonetti L, Rossetti L, Bertelli M. Mutation profile of BBS genes in patients with Bardet-Biedl syndrome: an Italian study. Ital J Pediatr. 2019 Jun 13;45(1):72. doi: 10.1186/s13052-019-0659-1. Citation on PubMed
  • Melluso A, Secondulfo F, Capolongo G, Capasso G, Zacchia M. Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook. Ther Clin Risk Manag. 2023 Jan 30;19:115-132. doi: 10.2147/TCRM.S338653. eCollection 2023. Citation on PubMed
  • Muller J, Stoetzel C, Vincent MC, Leitch CC, Laurier V, Danse JM, Helle S, Marion V, Bennouna-Greene V, Vicaire S, Megarbane A, Kaplan J, Drouin-Garraud V, Hamdani M, Sigaudy S, Francannet C, Roume J, Bitoun P, Goldenberg A, Philip N, Odent S, Green J, Cossee M, Davis EE, Katsanis N, Bonneau D, Verloes A, Poch O, Mandel JL, Dollfus H. Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease. Hum Genet. 2010 Mar;127(5):583-93. doi: 10.1007/s00439-010-0804-9. Epub 2010 Feb 23. Citation on PubMed or Free article on PubMed Central
  • Pomeroy JJ, Richards J, Sweeney BR, Kumar S, Queen KE, Zaritsky J, Cramer CH, Traboulsi EI, Scruggs BA, Davis EE, Keifer E, McGibbon E, Ogden T, De Graaf B, Hymers T, Forsythe E, Beales P. Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria. Am J Med Genet A. 2026 May 23. doi: 10.1002/ajmg.a.70199. Online ahead of print. Citation on PubMed
  • Shoemaker A. Bardet-Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best-practice management. Diabetes Obes Metab. 2024 Apr;26 Suppl 2:25-33. doi: 10.1111/dom.15494. Epub 2024 Feb 21. Citation on PubMed
  • Tobin JL, Beales PL. Bardet-Biedl syndrome: beyond the cilium. Pediatr Nephrol. 2007 Jul;22(7):926-36. doi: 10.1007/s00467-007-0435-0. Epub 2007 Mar 15. Citation on PubMed
  • Tomlinson JW. Bardet-Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction. Diabetes Obes Metab. 2024 Apr;26 Suppl 2:13-24. doi: 10.1111/dom.15480. Epub 2024 Feb 1. Citation on PubMed
  • Yildiz Bolukbasi E, Mumtaz S, Afzal M, Woehlbier U, Malik S, Tolun A. Homozygous mutation in CEP19, a gene mutated in morbid obesity, in Bardet-Biedl syndrome with predominant postaxial polydactyly. J Med Genet. 2018 Mar;55(3):189-197. doi: 10.1136/jmedgenet-2017-104758. Epub 2017 Nov 10. Citation on PubMed
  • Zaghloul NA, Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest. 2009 Mar;119(3):428-37. doi: 10.1172/JCI37041. Epub 2009 Mar 2. Citation on PubMed or Free article on PubMed Central

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.